Clinical Trial

Iatrogenic Deficiencies in ICU Patients With Prolonged Continuous Renal Replacement Therapy

Study acronym: IBRIST
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
ICU patients are recruited after at least 5 days treatment with continuous renal replacement therapy. Blood samples are drawn at time of recruitment and then every 3-5 days until ceseation of renal replacement therapy. Samples will be analyzed for concentrations of trace elements, vitamins and amino acids. 10 adult ICU patients treated for two weeks without renal replacement therapy will be sampled at one time point to serve as controls.
Trial Details
NCT Number NCT06983197
Lead Sponsor Karolinska University Hospital
Conditions Acute Kidney Injury
Enrollment 30 participants
Start Date 2025-06-01
Primary Completion 2028-12-31 (estimated)
Study Completion 2029-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-21